• JUNE
    5

    Infinity to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
    READ MORE >>

  • JUNE
    3

    Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in B-Cell and T-Cell Lymphomas at ASCO Annual Meeting and Announces Initiation of Phase 2 Clinical Study in Indolent Non-Hodgkin Lymphoma
    READ MORE >>

  • JUNE
    2

    Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO Annual Meeting
    READ MORE >>